FDA OKs first drug made to reduce excessive sweating

June 2018 -- The first drug developed specifically to reduce excessive sweating, a common condition that can cause people anxiety and affect their social lives, has been approved.

The Food and Drug Administration approved Qbrexza for excessive underarm sweating and will be available in October 2018. The drug is inside a cloth wiped over the skin daily to block sweat glands from activating.

Read More


Share this article